The cardiovascular risks of etoricoxib (Arcoxia).
Sasich
Larry D
LD
Barasain
Mohammed A
MA
Al Kudsi
Mohammed A
MA
D002318:Cardiovascular Diseases / Q000139:chemically induced*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D017277:Drug Approval; D000077613:Etoricoxib; D006801:Humans; D011725:Pyridines / Q000009:adverse effects*; D012529:Saudi Arabia; D013450:Sulfones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D016861:Cyclooxygenase Inhibitors; D011725:Pyridines; D013450:Sulfones; D000077613:Etoricoxib